News

Targeted Oncology5h
Expanded Approaches Focus on Balancing Efficacy and Toxicity in NSCLC
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.
Doctors said I was ‘too young’ to be seriously ill. I had Stage 4 cancer.
Three years ago, before I learned that I had metastatic cancer, doctors repeatedly told me I was “too young” to be seriously ...
Agence France-Presse1d
Phase 3 Data for Incyte’s Retifanlimab (Zynyz®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet
The publication, entitled “Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 ...
CURE3d
The LAURA Trial May Lead to a New Era of Care in Lung Cancer
Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell ...
Sportschosun on MSN3d
Lungs that don't talk even if they're sick...Low-dose CT recommended for smokers over 55 years of ag...
Lung cancer is a dangerous disease that ranks first in cancer mortality in Korea, and there are few initial symptoms, making ...
Everyday Health on MSN6d
When Non-Small Cell Lung Cancer Spreads: What to Expect
What to know about new diagnostic tools, targeted medications, and other recent advances in the treatment of metastatic NSCLC ...